Clinical trial Recruiting at 1 site Interventional Ages 50 to 75

Ear vagus nerve stimulation plus TENS to improve arm movement after stroke

Official title: Effect of Combining Transcutaneous Vagus Nerve Stimulation With Peripheral Nerve Stimulation on Upper Limb Motor Function in People With Stroke: A Single- Blinded Randomised Controlled Trial

Run by The Hong Kong Polytechnic University · NCT07425756 · Data updated 2026-11-12

This study will test whether combining gentle ear vagus nerve stimulation with TENS and task-focused practice can help improve upper‑limb movement in people more than six months after a stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages50 Years to 75 Years
SexAll
Enrollment120 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Kowloon)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedFebruary 23, 2026
Trial IDNCT07425756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 55–75 who are at least six months post‑stroke, can communicate, and have minimal antigravity shoulder movement and at least 5° wrist extension.

Probably not a fit

Patients with other neurological diseases, unstable medical conditions, implanted brain metal, a history of seizures, or those with little to no voluntary wrist/shoulder movement are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a blinded, randomized controlled trial that pairs transcutaneous auricular vagus nerve stimulation (taVNS) and transcutaneous electrical nerve stimulation (TENS) with task‑oriented training for upper limb recovery after stroke. Participants are randomized to active or sham versions of the peripheral and auricular stimulations while performing repetitive, goal‑directed arm tasks. Eligible participants are 55–75 years old, at least six months post‑stroke, and have some preserved shoulder and wrist movement. Outcomes will focus on changes in motor function of the paretic upper limb over the intervention period.

Why it matters

Potential benefit: If successful, the approach could modestly improve arm strength and function and make daily tasks easier for people living with chronic stroke.

How similar studies have gone: Prior invasive and noninvasive vagus nerve stimulation studies paired with rehabilitation have shown promise for improving post‑stroke motor recovery, and transcutaneous approaches are newer but supported by early positive results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 55 - 75 years old;
2. diagnosed with stroke confirmed by magnetic resonance imaging or computed tomography for more than 6 months;
3. had volitional control of the non-paretic arm and at least minimal antigravity movement in the paretic shoulder;
4. had at least 5 degrees of wrist extension in the antigravity position;
5. be able to communicate

Exclusion Criteria:

1. had neurological disease other than stroke, e.g., Parkinson's disease or dementia;
2. ongoing healthy condition, e.g., angina pectoris, pain, or arthritis;
3. had any contraindications of taVNS (metal implants in the brain, history of seizure)

Where it's running

  • The Hong Kong Polytechnic University
    Kowloon, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.